STERIS R&D increased by 4.6% to $29.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $27.40M to $29.50M. Over 3 years (FY 2022 to FY 2025), R&D shows an upward trend with a 7.5% CAGR.
Analysis
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_developmentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.19M | $18.83M | $24.82M | $24.82M | $24.75M | $24.93M | $25.51M | $23.28M | $24.69M | $26.27M | $25.26M | $27.46M | $25.60M | $27.00M | $27.40M | $27.65M | $26.40M | $28.20M | $29.50M |
| QoQ Change | — | +3.5% | +31.8% | -0.0% | -0.3% | +0.7% | +2.4% | -8.7% | +6.1% | +6.4% | -3.9% | +8.7% | -6.8% | +5.5% | +1.5% | +0.9% | -4.5% | +6.8% | +4.6% |
| YoY Change | — | — | — | — | +36.1% | +32.4% | +2.8% | -6.2% | -0.2% | +5.4% | -1.0% | +17.9% | +3.7% | +2.8% | +8.5% | +0.7% | +3.1% | +4.4% | +7.7% |
Business Segments
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences: | — | — | — | — | — | — | $2.70M | $2.80M |
| Life Science Member | $2.06M | $2.06M | $2.06M | $2.06M | $2.20M | $2.40M | — | — |
| Total | $24.69M | $26.27M | $25.26M | $27.46M | $25.60M | $26.40M | $28.20M | $29.50M |
Life Science Member was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
R&D at Other Companies
Frequently Asked Questions
- What is STERIS's r&d?
- STERIS (STE) reported r&d of $29.50M in Q4 2025.
- How has STERIS's r&d changed year-over-year?
- STERIS's r&d increased by 7.7% year-over-year, from $27.40M to $29.50M.
- What is the long-term trend for STERIS's r&d?
- Over 3 years (2022 to 2025), STERIS's r&d has grown at a 7.5% compound annual growth rate (CAGR), from $86.66M to $107.65M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.